Compound 2k induced a concentration-dependent increase in acetylation of the Sirt1 substrate p53 in HCT116 colon cancer cells co-treated with etoposide, consistent with on-target cellular Sirt1 inhibition [232]. Here, TP53 is linked to colonic neoplasm.